This specific ISBN edition is currently not available.View all copies of this ISBN edition:
Over the past decade, the transient gene expression (TGE) technology platform has been actively pursued to produce a wide range of therapeutic proteins, monoclonal antibodies, and vaccines for mainly preclinical assessment, due to its short development times and low overall cost.
This book updates the latest advances in the field, with focusing on systematic description of the technology from cell lines, cell culture conditions, vector construction, expression strategy, current protocols, optimisation of the procedure, and potential for clinical application. As a conclusion, the author foresees that therapeutic biopharmaceutics will be manufactured for clinical development using TGE technology in the near future because of its fast development time, good protein expression, acceptable quality of product and due to the progress which has been made in analytical methodology and process quality control.
The objectives of this book are to summarise current TGE protocols, to describe optimisation of the technology through the latest advances, and to explore clinical applications of the technology. It gives the reader a good insight into the latest development and future application of the technology platform, including:
"synopsis" may belong to another edition of this title.
Book Description Smithers Rapra Technology, 2013. Hardcover. Condition: New. Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. Buy with confidence, excellent customer service!. Seller Inventory # 1847359760n
Book Description Smithers Rapra Technology, 2018. Hardcover. Condition: New. Never used! This item is printed on demand. Seller Inventory # P111847359760
Book Description Smithers Rapra Technology, 2013. Hardcover. Condition: Brand New. 186 pages. 9.69x6.61x0.87 inches. In Stock. Seller Inventory # zk1847359760
Book Description Smithers Rapra Technology, 2013. Condition: New. book. Seller Inventory # M1847359760